Sutro Biopharma (STRO) Revenue (2017 - 2026)
Sutro Biopharma's Revenue was $9.84 million in Q2 2026, down 84.6% from $63.75 million a year earlier.
Powered by 
Analysis
Sutro Biopharma (STRO) Revenue (2017 - 2026) Analysis & Trends
On a trailing twelve-month basis, Sutro Biopharma's Revenue was $94.92 million through Jun 30, 2026, down 9.1% year-over-year; for FY2025, it was $102.48 million, up 65.2% from FY2024.
- Revenue shows a five-year compound annual growth rate of 19.1% (FY2020 to FY2025).
- In earlier years, Revenue was $62.04 million in FY2024 (-59.6%), $153.73 million in FY2023 (+126.8%), $67.77 million in FY2022 (+9.5%) and $61.88 million in FY2021 (+44.8%).
- Quarterly Revenue has moved between $5.9 million (Q1 2022) and $113.72 million (Q4 2023) over five years.
- Compared with a year earlier, Revenue was higher in three of the last seven quarters, with an average decline of 6.7%.
- The best year-over-year quarter for Revenue over five years was Q3 2022 (growth of 195.3%); the worst was Q4 2024 (a decline of 87.0%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Sutro Biopharma | 265.72 Mn | -412.78 Mn | - | 9.84 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.84 Mn |
| Dec 31, 2025 | 11.65 Mn |
| Sep 30, 2025 | 9.69 Mn |
| Jun 30, 2025 | 63.75 Mn |
| Mar 31, 2025 | 17.40 Mn |
| Dec 31, 2024 | 14.81 Mn |
| Sep 30, 2024 | 8.52 Mn |
| Jun 30, 2024 | 25.71 Mn |
| Mar 31, 2024 | 13.01 Mn |
| Dec 31, 2023 | 113.72 Mn |
| Sep 30, 2023 | 16.92 Mn |
| Jun 30, 2023 | 10.41 Mn |
| Mar 31, 2023 | 12.67 Mn |
| Dec 31, 2022 | 8.63 Mn |
| Sep 30, 2022 | 25.15 Mn |
| Jun 30, 2022 | 28.10 Mn |
| Mar 31, 2022 | 5.90 Mn |
| Dec 31, 2021 | 10.65 Mn |
| Sep 30, 2021 | 8.52 Mn |
| Jun 30, 2021 | 28.05 Mn |
API Access
Sutro Biopharma Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=STRO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "STRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=STRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();